ENTITY
SMARTSCORE: 3.2/5
Macrogen Inc

Macrogen Inc (038290 KS)

8
Analysis
Health Care • South Korea
Macrogen Inc. provides DNA sequencing and genome research services. The Company also raises and sells transgenic and knockout mice to biotechnology institutes and pharmaceutical companies. Macrogen develops DNA chips, which are used to improve the diagnosis and treatment of disease as well.
more
bullish•Twist Bioscience
•16 Dec 2024 09:46

DNA Synthesis with a Silicon Twist

Twist's fast, cheap DNA synthesis will power biotech start-ups, driving demand, fostering loyalty, enabling innovation, and securing new and...

Logo
281 Views
Share
•26 Nov 2020 13:49
Smartkarma Originals

Asian Healthcare - Coming of Age

This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...

Share
•10 Mar 2020 16:58

Full Details & Current Designation List - Short-Selling Restriction Rule Change in Korea

It is now official that we have a new short-selling restriction rule, which is effective as of March 11. For the existing regulations, we now have...

Logo
446 Views
Share
bullish•Macrogen Inc
•20 Jul 2018 08:20

CV Note: Macrogen (038290 KQ)

"Korea’s #1 and the world’s #5 NGS player" The world’s 5th ranked DNA sequencing service provider. Growing NGS (Next Generation Sequencing) market...

Logo
654 Views
Share
bearish•Celltrion Inc
•10 Aug 2017 11:54

NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move

Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...

Logo
1.6k Views
Share
x